REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Gom-7 ZAO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka Gom-7 ZAO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Apteka Gom-7 ZAO is a company in Russia, with a head office in Moscow. It operates in the Pharmacies and Drug Stores industry. The company was established on August 19, 2002. The latest financial highlights indicate a net sales revenue increase of 12.75% in 2023. Its’ total assets recorded a negative growth of 3.8%. The net profit margin of Apteka Gom-7 ZAO increased by 4.52% in 2023.

Headquarters
Entuziastov, 64
Moscow; Moscow; Postal Code: 111123

Contact Details: Purchase the Apteka Gom-7 ZAO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Gom-7 ZAO report to view the information.
Registered Capital:
Purchase the Apteka Gom-7 ZAO report to view the information.
Incorporation Date:
August 19, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Assotsiatsiya Gomeopaticheskoi Farmatsii Kontinentalnaya (Nekommercheskaya Organizatsiya)
25%
Company Performance
Financial values in the chart are available after Apteka Gom-7 ZAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
12.75%
Total operating revenue
12.75%
Operating profit (EBIT)
138.54%
Net Profit (Loss) for the Period
253.97%
Total assets
-3.8%
Total equity
36.11%
Operating Profit Margin (ROS)
5.67%
Net Profit Margin
4.52%
Return on Equity (ROE)
-45.68%
Debt to Equity Ratio
2.03%
Quick Ratio
0.13%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?